University of Texas MD Anderson Cancer Center [clinicaltrials_resource:d943b857d2de2308c1d8c2adaae6c788]
High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors [clinicaltrials:NCT00037869]Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients [clinicaltrials:NCT00038142]clinicaltrials:NCT00050531clinicaltrials:NCT00059631clinicaltrials:NCT00076310RAD001 in Recurrent Endometrial Cancer Patients [clinicaltrials:NCT00087685]clinicaltrials:NCT00102648clinicaltrials:NCT00113334clinicaltrials:NCT00129740Neoadjuvant, Tarceva, Surgery for Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00254384]clinicaltrials:NCT00254410clinicaltrials:NCT00254423clinicaltrials:NCT00290433Rituximab-HCVAD in Patients With B-Cell Non-Hodgkin's Lymphoma [clinicaltrials:NCT00290498]Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular Lymphoma [clinicaltrials:NCT00290511]clinicaltrials:NCT00294632Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma [clinicaltrials:NCT00307177]clinicaltrials:NCT00317772clinicaltrials:NCT00329043Letrozole (Femara) Plus Imatinib Mesylate (Gleevec) for Breast Cancer Patients [clinicaltrials:NCT00338728]Elizabeth Registry for Low Grade Ovarian Cancer [clinicaltrials:NCT00345709]clinicaltrials:NCT00349596Prognostic Molecular and Environmental Factors in High-Risk Colon Cancer Patients [clinicaltrials:NCT00354705]clinicaltrials:NCT00381004Risk Perception Among Quitting Smokers [clinicaltrials:NCT00384696]Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease [clinicaltrials:NCT00385788]Spousal Relationships and Pain in Metastatic Breast Cancer [clinicaltrials:NCT00386620]Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma [clinicaltrials:NCT00386906]clinicaltrials:NCT00390793Targeted Intervention for Melanoma Prevention [clinicaltrials:NCT00394134]Phase 1, Multiple Dose Study of MPC-6827 in Subjects With Refractory Solid Tumors [clinicaltrials:NCT00394446]clinicaltrials:NCT00402766BATTLE Program: Umbrella Protocol for Patients With NSCLC [clinicaltrials:NCT00409968]clinicaltrials:NCT00410059BATTLE Program: Tarceva and Targretin in Patients With NSCLC [clinicaltrials:NCT00411632]Smoking Status and Body Image in Oral Cancer Patients [clinicaltrials:NCT00412490]All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab [clinicaltrials:NCT00413166]clinicaltrials:NCT00413478Effects of Pomegranate Juice or Extract on Rising PSA Levels in Men Following Primary Therapy for Prostate Cancer [clinicaltrials:NCT00413530]clinicaltrials:NCT00414310
location [clinicaltrials_vocabulary:location]
University of Texas MD Anderson Cancer Center [clinicaltrials_resource:d943b857d2de2308c1d8c2adaae6c788]
Bio2RDF identifier
d943b857d2de2308c1d8c2adaae6c788
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:d943b857d2de2308c1d8c2adaae6c788
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:d943b857d2de2308c1d8c2adaae6c788
title
University of Texas MD Anderson Cancer Center
@en
type
label
University of Texas MD Anderso ...... 3b857d2de2308c1d8c2adaae6c788]
@en